Treatment of a fully permissive monkey kidney cell clone (CV1Cll) with 5-iodoz'-deoxyuridine (IdUrd) before infection with SV4o virus enhances the yield of virions 1o-to 5o-fold. The increase is detectable only after slowing down the virus growth cycle by reducing the m.o.i, and by incubating at low temperature. The IdUrd pre-treatment enhances SV4o DNA replication and the number of Vantigen and virus-synthesizing cells. The potentiating effect of IdUrd is not observed when the pre-treated cells are infected with SV4o DNA. The synthesis of SV4o T-antigen is increased even in the presence of cytosine arabinoside (Ara-C). IdUrd inhibits cellular DNA synthesis but the incorporation of 3H-uridine and 3H-leucine into RNA and proteins is not affected. Late virus functions are preferentially expressed in the cells in which cellular DNA synthesis is inhibited. The results suggest that the enhancement by IdUrd of SV4o replication would be the consequence of at least two complementary events: (0 stimulation of an early virus function localized between the arrival of the virus DNA in the nucleus and T-antigen induction; (2) inhibition of cellular DNA synthesis with a consequent greater availability of cellular factors required for virus growth.
Treatment of a fully permissive monkey kidney cell clone (CV1Cll) with 5-iodoz'-deoxyuridine (IdUrd) before infection with SV4o virus enhances the yield of virions 1o-to 5o-fold. The increase is detectable only after slowing down the virus growth cycle by reducing the m.o.i, and by incubating at low temperature. The IdUrd pre-treatment enhances SV4o DNA replication and the number of Vantigen and virus-synthesizing cells. The potentiating effect of IdUrd is not observed when the pre-treated cells are infected with SV4o DNA. The synthesis of SV4o T-antigen is increased even in the presence of cytosine arabinoside (Ara-C). IdUrd inhibits cellular DNA synthesis but the incorporation of 3H-uridine and 3H-leucine into RNA and proteins is not affected. Late virus functions are preferentially expressed in the cells in which cellular DNA synthesis is inhibited. The results suggest that the enhancement by IdUrd of SV4o replication would be the consequence of at least two complementary events: (0 stimulation of an early virus function localized between the arrival of the virus DNA in the nucleus and T-antigen induction; (2) inhibition of cellular DNA synthesis with a consequent greater availability of cellular factors required for virus growth.
INTRODUCTION
Treatment of cells with the thymidine analogue 5-iodo-2'-deoxyuridine (IdUrd) before infection with different viruses (human and murine cytomegalovirus, human adenovirus 7, rubella, vesicular stornatitis, Sindbis, mouse encephalitis and vaccinia viruses) increases virus replication (St Jeor & Rapp, 1973a, b; Paul et al. I974; Plummer & Goodheart, 1974; Green & Baron, 1975; Jerkofsky & Rapp, 1975; Staal & Rowe, 1975) . The mechanism of this effect is still unknown.
We have recently reported (Su~irez et al. I976 ) that IdUrd also enhances SV4o DNA and virion production in pre-treated Chinese hamster kidney (CHK) semi-permissive cells. Under the same experimental conditions, no effect by the drug on the replication of the virus was found when the experiments were carried out with fully permissive (monkey kidney) or non-permissive (mouse or Syrian hamster embryo) cells. Jerkofsky & Rapp (I975) reported that a decrease in the efficiency of SV4o replication was observed after pre-treatment with IdUrd of fully permissive primary African green monkey kidney (GMK) 
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Infection of cells with purified labelled virus or virus DNA. CV1Cll treated and untreated cells were infected with: (a) 3H-TdR-labelled SV4o (m.o.i. :5o p.f.u./cell; input radioactivity 1.6 × IO ct/min/culture). The virus was adsorbed for 2 h at 37 °C. The inoculum was removed and the cell monolayers were washed three times with serum-free medium. After the addition of maintenance medium the cells were incubated at 33 °C. The term 'after infection' used in the description of all experiments refers to the time interval after the addition of the virus; (b) purified 3H-labelled SV4o DNA form I (l'I #g/Petri dish; input radioactivity 1.45 x IO[ct[min[culture) , as described above for the non-purified virus DNA.
Disruption of cells and fractionation of cellular components. The techniques used for the disruption of cells and the fractionation of cellular components were those described by Barbanti-Brodano, Swetly & Koprowski 097o). SV4o DNA replication. The CV1CI~ treated and untreated cultures were labelled with aH-Tdr (z/ACi/ml) I2 h after infection (m.o.i. I p.f.u.]cell), in the presence of cold TdR (~/~g/ml). The virus DNA was extracted by the selective Hirt procedure at different times after infection and the newly synthesized DNA was separated in a CsCl-ethidium bromidedensity equilibrium gradient. The Hirt supernatant was mixed with CsC1 (density = t.576 g/ml at 25 °C) in a solution of o.m M-tris, pH 8, and 2oo/~g of ethidium bromide/ml. Equilibrium sedimentation was carried out for 48 h at 40000 rev/min at I5 °C in a Beckmann type 50 rotor. The tubes were punctured at the bottom and fractions were collected. Fractions from the form I supercoiled DNA were pooled and ethidium bromide was removed with iso-amyl alcohol. Form I DNA was then dialysed overnight against I x SSC (o'I5 M-NaC1, o.oI 5 M-sodium citrate, pH 7). DNA samples (o.[ ml) were layered on linear 5 to 20 neutral sucrose gradients (4"2 ml) in polyallomer tubes and sedimented at 4 °C in a Beckmann SW 56 rotor at 5500o rev/min for 3.25 h. Neutral gradients contained t M-NaC1, I mM-EDTA and Io mM-tris, pH 7"4. The tubes were punctured at the bottom and fractions of eight drops were collected on to 2"5 cm diam. Carl Schleicher and Schull paper discs, dried, washed three times in 5 ~ trichloracetic acid (TCA) and then once in ethanol. After drying, the discs were counted in an Intertechnique liquid scintillation counter (ABAC type, SL 40, France). Purified 3H-labelled SV4o DNA component I was used as a marker.
Synthesis of infectious
Infectious centre assays. The assays were carried out as follows: (a) a small number 0oo, 50 and IO) of IdUrd-treated or untreated virus-infected (m.o.i.o.~ or I p.fiu./cell) CV1Cll cells to be tested was plated with IO G non-infected CV~CI~ cells on to 6 cm diam. Falcon plastic dishes. The dishes were incubated overnight at 33 °C to allow cell attachment. The fluid growth medium was then replaced by an agar overlay and the cultures were incubated at 33 °C in air with 5 ~ COs. The number of plaques formed was counted ~4 days later; (b) samples of the treated and untreated infected cells were seeded in 25 cm 2 Falcon plastic flasks and on to coverslips, and incubated at 33 °C. Seventy-two hours later, the flasks were 36-~ frozen and thawed three times, sonicated for 4 min at low frequency at 4 °C, and the virus yield per culture was established by plaque formation on CVtClt monolayers. The coverslips were fixed for V-antigen determination as described below.
Synthesis of cellular DNA, RNA and proteins. IdUrd-treated and untreated CV~CI~ cells seeded in Petri dishes (6 cm diam.) were mock infected. After 2 h at 37 °C, the cultures were handled as described for SV4o infection and incubated at 33 °C. At various times after the end of IdUrd treatment, labelling was performed by addition of i #Ci of 3H-TdR, ~H-leucine or aH-uridine per ml for periods of 2 h. In the case of 3H-leucine, the cells were incubated in leucine-free culture medium containing 2 ~ dialysed calf serum before adding the label. At the end of each labelling period the dishes were washed three times with cold TBS, trypsinized and after washing again with cold TBS, the cellular pellet was resuspended in 5 ~ TCA. The acid-insoluble material was collected by filtration on to glass-fibre filters GF/C (Whatman) and washed three times with 5 ~ TCA. Radioactivity was measured in a liquid scintillation counter. Each culture was counted after trypsinization to determine the number of cells at each time and the amount of DNA, RNA and proteins was expressed as ct/min/m 6 cells.
Autoradiography. Untreated and IdUrd-treated CV~CI~ cells grown on coverslips (I2 x 22 mm) in 6 cm diam. Petri dishes were infected with virus, washed, treated with anti-virus rabbit serum and incubated after washing as described above. At fixed times after infection, the cultures were labelled for z h periods with 3H-TdR (~ #Ci/ml). At the end ofthelabelling period, the coverslips were rinsed with TBS, fixed with cold acetone, air-dried and stained for SV4o V-antigen determination by the indirect immunoperoxidase technique of Wicker & Avrameas (I969). The coverslips were then mounted on glass slides (cell side up), coated with a Kodak AR to fine grain autoradiographic film and stored at 4 °C. After an appropriate exposure time, the autoradiograms were developed with Kodak D-I9 developer, stained with 0"03 ~ aqueous methylene blue, and V-antigen and autoradiographic grains were viewed by light microscopy. 
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RESULTS
IdUrd enhancement of SV4o yieM
In a previous publication we reported that IdUrd was unable to enhance SV4o virus production in CV~C11 cells (Sufirez et al. I976 ) . However, we have repeatedly observed that early after infection (24 h), the total yield of virus produced in pre-treated cultures was significantly higher than that in control cultures; yet, this difference was rapidly abolished. This suggested that, by slowing down the virus growth cycle, it could be possible to show an effect of IdUrd even on fully permissive infected cells. In order to verify this hypothesis, the effect of IdUrd on CV1Cll cells was tested by infecting the pre-treated cultures at low m.o.i. and incubating them at low temperature.
CV1CI~ cells were seeded in Falcon plastic flasks (2 5 cm~), in the presence or absence of IOO #g/ml of IdUrd, and were incubated at 37 °C for 96 h. The toxic effect of IdUrd on cells was not marked; however, the treated CV~CI~ cells were larger than the controls. The drug inhibited cell division so that at the time of infection there was about 50 ~ reduction in cell number compared with controls SV4o was added 2 h after the removal of the drugcontaining medium. After adsorption and removal of the residual virus, maintenance medium containing no drug was placed on all cultures and these were incubated at 33 °C.
Virus was harvested at 72 h (except for kinetic studies) and samples were assayed for virus yield. Under these experimental conditions, IdUrd pre-treatment reproducibily enhanced (IO-to 5o-fold) the yield of virus. This increase was more significant at lower m.o.i. (see below). For unknown reasons, at a given m.o.i, variations in virus yield were observed throughout this study. Fig. I shows a kinetic study of the infectious virus production in treated and untreated CVIC11 cells. In this experiment, the enhancement was maximal at 48 h and 72 h (I7-5-and 5o-fold respectively) and the difference decreased progressively at later times. These results suggest an acceleration in production of infectious virus by treated cells. This enhancement was not due to a faster cell growth as IdUrd treatment inhibited cellular DNA synthesis (see below) and cell multiplication for at least I44 h after removal of the drug. However, this effect was reversible and the treated cells progressively resumed a normal growth rate at later times (data not shown).
Different concentrations of the drug (Io and 5o #g/ml) and shorter treatments (24, 48 and 72 h) with a fixed dose (Ioo #g/ml) were less effective in stimulating the virus production (data not shown). * Experimental conditions were those described in Methods, Determination of SV40 virus yield was done at 72 h post-infection. The increase is the difference in titre compared to the untreated control.
Effect of temperature and m.o.i, on the replication of SV4o in IdUrd-treated CVIClx cells
CV1CIx cells were grown in the presence or absence of IdUrd as described in Methods and after infection were incubated at 33, 37 and 4I °C for 24, 48, 72 and 96 h. As shown in Fig. 2 , in treated ceils the virus yield was significantly increased 24 h after infection at the three temperatures. Later, at 37 and 4t °C, the difference decreased progressively until it completely disappeared at 96 h; in contrast, a significant difference persisted until 96 h when the cultures were incubated at 33 °C. These results indicate that, by slowing the SV4o growth rate at 33 °C, a prolonged enhancement of the virus yield is clearly seen.
As indicated in the experiment shown in Table I , when pre-treated or control CV1CI~ cells were infected at different m.o.i. (O'I, I and ~o p.f.u./cell) and incubated at 33 °C, the increase was least or nil at the high m.o.i, and was greatest at the low m.o.i. (ranging from a minimum of 1.2-fold to a maximum of about 15-fold in the present experiment). This finding suggests that even at 33 °C the increase in the rate of virus production is no longer detectable when the permissive cells are infected at high multiplicities.
Virus DNA synthesis in IdUrd-treated and control cells
The pre-treated or control CVICll cells, infected and incubated as described in Methods, were examined to determine the rate of virus DNA synthesis. Cells were labelled from I2 to 72 h post-infection with 3H-TdR, in the presence of cold TdR. Fig. 3(a) shows that pretreatment of the cells with IdUrd significantly enhanced replication of form I (supercoiled) DNA, when the Hirt supernatants were analysed by CsCl-ethidium bromide density gradient centrifugation. The fractions of form I DNA were pooled and further analysed by sucrose gradient centrifugation (5 to 20 ~) at neutral pH. The results are presented in Fig. 3(b) . The sedimentation profiles showed a peak of heavy material in fractions 9 to I2 which corresponds to mitochondrial DNA and was also present in extracts from noninfected cells (not shown). In addition, a peak of radioactivity sedimenting at the position of SV4o DNA component I was observed in the extracts from the infected cells. The material in that peak had the same sedimentation coefficient (2IS) as that of marker SV4o form I DNA. About seven times more counts were recovered in 2IS virus DNA from the IdUrdtreated cells. Fig. 4 shows the cumulative incorporation of 3H-TdR into 2IS SV4o DNA in cultures labelled at I2, 24, 36, 48 or 72 h post-infection. Assuming that the pool size of nucleotides was comparable in control and treated cultures, the data indicate that the amount of virus DNA synthesized between 24 and 72 h was significantly higher in the IdUrd-treated cells. This increase is underestimated since, in treated cultures, the number of cells was markedly lower than in the controls. The Hirt supernatants from each sample were also titrated on CV1Cli cells to measure the quantity of infectious SV4o DNA. Fig. 4 shows that, between 24 and 72 h after infection, the treated cells produced from 5-to 22-fold more p.f.u./IO 6 cells than the controls.
Infectious centres assay
The effect of pre-treatment with IdUrd on the ability of CV1C11 cells infected with SV4o virus to produce infectious centres was determined as described in Methods. Different Table 2 . The number of treated CV~CI~ cells forming infectious centres was approximately three-to fourfold greater than in the control and this was confirmed in two other independent experiments. Therefore, IdUrd enhanced the number of cells capable of releasing infectious virus. The increase in the number of IdUrd-treated cells able to synthesize V-antigen and to produce infectious centres was of the same order at both m.o.i. In these experiments IdUrd treatment enhanced the virus yield 7 to 4o-fold 72 h after infection.
Induction of SV4o T-and V-antigen
Immunofluorescence and complement fixation techniques were used to determine the effect of IdUrd pre-treatment on the induction of SV4o-specific T-and V-antigens. The results are presented in Table 3 . IdUrd pre-treatment increased the synthesis of T-antigen as determined by both complement fixation and immunofluorescence methods at 24 and 71 h after infection with the virus. These results suggested that the action of the analogue was exerted early in the virus cycle, prior to the antigen synthesis. To confirm whether this hypothesis was true, the synthesis of T-antigen was measured in pre-treated and control cultures submitted immediately after infection to the action of Ara-C, an inhibitor of DNA synthesis. The enhancement of T-antigen induction in the IdUrd-treated cultures persisted in the presence of Ara-C (5/~g/ml), z4 h after infection.
The production of V-antigen was also increased in the cultures pre-treated with IdUrd when measured by either complement fixation or immunofluorescence. As expected, Ara-C completely inhibited synthesis of the antigen when examined by immunofluorescence 24 or 72 h after infection.
Kinetics of adsorption and penetration of SV4o virus in IdUrd-treated CV1Cll cells
As shown in Table 3 , IdUrd pre-treatment increased SV4o T-antigen production in CV1Cll cells whether submitted or not after infection to the action of Ara-C. These results suggest 
. Kinetics of adsorption of SV4o on to IdUrd-treated (O---O) and untreated (O----O)
CV1Cll cells. After incubation with 3H-TdR-labelled SV4o at a m.o.i, of 5o p.f.u./cell (input radioactivity 1.6 x io ¢ ct/min/culture), the infected cultures were incubated at 37 °C. At intervals after infection, the inoculum was removed, the cells washed three times with TBS and harvested into a final volume of 2 ml. The acid-precipitable radioactivity in the cell suspension was determined.
that the analogue treatment affects an early stage of the virus cycle, preceding T-antigen production. To establish whether IdUrd acts on the adsorption, penetration or transport of virus or virus DNA in the cell, the following experiments were done. Control and IdUrdtreated CV~Cll cells were infected with purified labelled virus. At various intervals after infection the cells were treated by the techniques cited in Methods and the acid-precipitable radioactivity of total cell suspensions or cell fractions was determined. Fig. 5 shows that there was no difference in SV4o adsorption in treated or untreated cells. Within I5 min, 25 To of the input radioactivity of the ~H-TdR-labelled virus became cell-associated. The rate of adsorption then increased more slowly, about 50 ~ of the total input radioactivity being adsorbed 2 h after infection.
The distribution of the ~H-TdR-labelled virus component between the cytoplasm and the nuclei of infected cells was determined for the period from 2 to I2 h after infection (Fig.  6 a, b) . The time dependence of the distribution and the extent of radioactivity incorporated in the nuclei and cytoplasm followed a similar pattern in treated and control cells. At 3 h after infection, approximately 75 ~ of the cell-associated radioactivity was found in the nuclei. Between 3 and 6 h, the release of the radioactive precursor from the nuclei was accompanied by a complementary increase in the cytoplasmic fraction. Later, a decrease in radioactivity of both the nuclear and cytoplasmic fractions was observed. These experiments indicate that the analogue acts at a step of the virus cycle between the arrival of virus DNA in the nucleus and the T-antigen synthesis.
Infection of ldUrd-treated CVICI1 cells with SV4o-DNA
We had previously shown that in a semi-permissive system the enhancement of the virus yield and T-antigen synthesis in the IdUrd pre-treated cells was comparable after infection by SV4o virus or virus DNA (Su~irez et al. I976) . To confirm these results in CV1CI~ cells, the analogue-pre-treated cells were infected with virus DNA as described in Methods. Seventytwo hours later, the cultures were harvested and the rate of virus production was determined. [ #g/Petri dish; input radioactivity 1"45 x I O 4 ct/min/culture), the cells were harvested and handled as described in Fig. 6 . The acid-precipitable radioactivity in the cytoplasmic (a) and in the nuclear (b) fractions was determined.
Samples of the treated and untreated infected cells were seeded on coverslips to measure the T-antigen synthesis. Table 4 shows that, after infection with the virus DNA, there was neither enhancement of the rate of virus production nor of the number of T-antigen positive cells in the treated cultures. The contradiction between these results and those obtained with CHK cells raised the question of whether in IdUrd-treated CV1Cll cells the penetration or the stability of the SV4o DNA was affected. To clarify this point the following experiment was carried out. IdUrd-treated or untreated CV1CI1 cells were infected with purified labelled form I SV4o DNA and at different times between 3o min and ]z h after infection, the cells were disrupted and fractionated as described by and the acid-precipitable radioactivity incorporated in the cell fractions determined. The results are presented in Fig. 7 -The cell-associated radioactivity in the cytoplasm and nuclei was constantly reduced to 65 to 75 ~ of the control values in the IdUrd-treated cells. However, the time dependence distribution of radioactivity in the nuclear and cytoplasmic fractions was the same in treated and control cells. The penetration of 3H-labelled SV4o DNA into the nuclei of the infected cells peaked at 4 h after infection irrespective of the IdUrd treatment and corresponded to approximately 50 ~ of the total cell radioactivity. 
Synthesis of cellular DNA, RNA and proteins in IdUrd-treated cells
The effect of IdUrd treatment on the synthesis of cellular DNA, RNA and proteins in CVICI 1 cells was studied by measuring the incorporation of 3H-TdR, aH-uridine and aH-leucine. IdUrd-pre-treated or untreated cultures were handled as described in Methods, except that they were not infected with the virus. At different times after treatment, they were labelled for z h with I #Ci/ml of each ~H-precursor and the acid-precipitable radioactivity was measured. The results obtained are summarized in Fig. 8 . The following points emerge from the experiments: (I) up to 48 h IdUrd treatment caused a two-to threefold inhibition of the cellular DNA synthesis. From 48 to 72 h the difference diminished progressively and at 72 h the precursor incorporation was higher in the treated cells, probably due to the fact that at about 48 h the control cultures reached confluence and stopped growing; (z) RNA synthesis was also inhibited by the drug in CV1C11 cells at I2 h. The difference between treated and untreated cultures disappeared gradually and at 72 h the treated cells showed an increased incorporation of 8H-uridine; (3) protein synthesis was enhanced at 48 and 72 h in the cultures submitted to the analogue treatment. This increase was probably due to the reasons stated in point I.
To establish whether there was a relationship between virus growth and cellular DNA synthesis, the same cell was examined by autoradiography and the immunoperoxidase technique. IdUrd-pre-treated and control cells, growing on coverslips, were infected with the virus. At different times after infection, they were labelled for 2 h with I #Ci/ml of 3H-TdR and at the end of the labelling period the coverslips were fixed, stained by the immunoperoxidase technique for V-antigen detection and 3H-TdR incorporation was determined by autoradiography as described in Methods (Table 5) . At different times after infection, except 72 h, cellular DNA synthesis was significantly decreased in the IdUrd-treated cells. As in previous experiments, the percent of V-antigen positive cells was enhanced in the treated cultures, but only 1"5 to 2"5 ~ of these cells synthesized cellular DNA against 6o to 7o ~ in the controls. These results suggest that in the IdUrd-treated cultures, SV4o V-antigen synthesis occurs preferentially in those cells in which cellular DNA synthesis is inhibited. ) and untreated (---), mock infected cells. The cultures were labelled for 2 h with I #Ci/ml of each ~H-precursor and the acid-precipitable radioactivity was determined at different times after the end of IdUrd treatment. (Green & Baron, I975) . The increase in replication of DNA viruses in IdUrd-pre-treated cells contrasts with the inhibition of these viruses when the drug is present during virus development. It has been shown that incorporation of IdUrd in the cellular DNA was necessary for the increase of human adenovirus 7 and SV4o yield (Staal & Rowe, ~975; Su~irez et aL I976) . However, the exact mechanism(s) of IdUrd enhancement of the replication of RNA and DNA viruses, with or without a nuclear mode of synthesis, is unknown. The results suggest that the potentiation of virus replication by the analogue is a widespread phenomenon. In the case of human adenovirus 7 and SV4o, with the experimental conditions employed in the papers cited above, no apparent effect of the drug was obtained when the experiments were carried out, pre-treating and infecting fully permissive cells. The results shown in the present work indicate that, by slowing down the virus cycle, it was also possible to obtain an enhancement by IdUrd of SV4o replication in CV1CI1 cells, a clone of fully permissive monkey kidney cells. Infecting the cells at a low m.o.i. (o.r to I p.f.u./cell) and incubating them at a low temperature (33 °C), under the conditions of single cycle replication, the rate of virus production in the treated cultures was Io-to 5o-fold greater than in controls. The increase was manifested in the treated cells by an enhanced replication of the virus DNA, as well as by a more rapid growth of the virus. The IdUrd pre-treatment, as shown for adenovirus 7 (Jerkofsky & Rapp, I975) and for human cytomegalovirus (St Jeor & Rapp, I973a ) , slightly increased the number of virus-producing cells.
The results of the experiments of uptake of aH-labelled SV4o DNA indicate that the total radioactivity incorporated in the cells was constantly reduced in the IdUrd-treated cultures. The decrease in the amount of T-antigen and virions, synthesized after infection with SV4o DNA, could either be explained by: (r) an ineffective penetration of the infectious DNA into the CV1Cll cells, because of a modification of the cellular membrane, consequent to the IdUrd treatment or (2) an enhanced instability of the DNA incorporated into these cells. An alternative possibility is that IdUrd increases the efficiency of conversion of the input SV4o virus to a form in which early transcription can begin. The purified infecting DNA might already be in this state. A different susceptibility to SV4o virus or virus DNA infection was described for two interferon-pre-treated monkey kidney cell lines by Yamamoto et al. (r975) . We have previously shown that in CHK cells pre-treated with IdUrd and infected by either SV4o virus or SV4o DNA, virus replication was similarly enhanced (Sufirez et al. I976 ). It appears, therefore, that monkey cells and Chinese hamster kidney cells have a different behaviour when they are treated with IdUrd.
T-antigen synthesis was increased in the IdUrd-pre-treated CVaCI~ cells. The enhanced antigen production persisted in spite of the addition of Ara-C immediately after the infection of cells, indicating that IdUrd acts at an early step of the virus cycle between the adsorption of the virus and T-antigen induction. That the drug may exert its effect at an early stage of infection is also suggested by the fact that: (I) T-antigen synthesis was also enhanced in the adenovirus 7 GMK cell system (Staal & Rowe, ~975) and in the SV4o CHK cell system (Su~irez et al. r976); (2) the IdUrd sensitive restriction for human cytomegalovirus in HEK cells occurs prior to virus DNA synthesis (St Jeor & Rapp, I973 b) . The experiments carried out to determine whether IdUrd affects the adsorption, penetration or transport of the virus in the cell indicate that the analogue acts between the arrival of virus DNA in the nucleus and the T-antigen synthesis. This suggests a possible action of IdUrd on the SV4o early transcription or translation. Results recently published by Speers & Lehman (r976) strengthens the hypothesis of a possible action of the halogenated pyrimidine on early transcription or translation. The authors reported that pre-treatment by BdUrd (another thymidine analogue) modifies the susceptibility of murine teratocarcinoma cells to SV4o and polyoma viruses, perhaps by removing a 'block' at the level of the early transcription or translation. Although T-antigen origin and function have not yet been exactly defined, recent observations indicate that the antigen might be involved in the initiation of virus DNA replication and might be a product of the 'early' A gene (May, May & Weil, r97i ; Tegtmeyer et al. I975; Graessmann, Graessmann & Mueller, I976 ) . Robb et al. (I974) , found that SV4o tsA mutants are unable to initiate virus DNA replication and do not induce normal levels ofT-antigen at a non-permissive temperature. Relevant to a possible role in DNA replication T-antigen binds to SV4 o DNA, preferentially at or near the origin of replication (Reed et al. I975) . Consequently, taking into account the results presented in our work, we propose as a working hypothesis that IdUrd acts by stimulating the synthesis of a virus-coded ' initiatior' of the SV4 o replication (T-antigen). Experiments are at present being carried out to establish whether early steps (transcription-translation) of the SV4o cycle are modified in IdUrd-pre-treated and virus-infected ceils.
It is interesting that IdUrd seems to act differently from mitomycin C, an alkylating agent which enhances SV4o replication in Chinese hamster pre-treated cells (Lavialle et al. I977) . The proportion of SV4o-infected cells synthesizing T-antigen was not significantly modified by pre-treatment with mitomycin C. Enhancement of cell permissiveness by mitomycin C may occur later in the virus cycle, between T-antigen induction and virus replication, perhaps by triggering the production of a cellular factor(s).
IdUrd pre-treatment of CV1C11 cells also increased the number of ceils synthesizing SV4o V-antigen. In a kinetic study combining the detection of V-antigen and cellular DNA synthesis in the same cell, the virus functions in the analogue-pre-treated cultures were preferentially expressed in cells not synthesizing DNA. Our results agree with those published by De Marchi & Kaplan 0976), who showed that after pre-treatment of human embryonic lung cells with 5-fluoro-uracil, human cytomegalovirus productive infection occurred mainly in cells in which cellular DNA synthesis was inhibited. IdUrd treatment markedly suppressed the synthesis of cellular DNA and affected cell division, without interfering with the incorporation of 8H-uridine into RNA and 3H-leucine into proteins. Assuming that the pool of precursors of the cellular macromolecules is not drastically modified in these cells, it can be postulated that a substantial number of cellular factors implicated in the cellular DNA metabolism, which are not used or are only partially utilized by the cells, remain available for the replication of the SV4o DNA and could contribute to the enhancing effect of IdUrd.
The results presented in this and previous papers (Jerkofsky & Rapp, I975; Staal & Rowe, 1975; Speers & Lehman, 1976; Sufirez et al. ~ 976) suggest that the IdUrd-potentiating effect of SV4o replication would result from two complementary events: (0 IdUrd incorporated in the cellular DNA acts early in the virus cycle stimulating the production of an 'initiator' of the SV4o replication (T-antigen), therefore enhancing the virus DNA synthesis and subsequently the late virus functions; (2) by inhibiting cellular DNA synthesis, IdUrd offers to the virus replication a surplus of factors implicated in the cellular DNA metabolism and which are not used by the cell. The demonstration of virus suceptibility to IdUrd potentiation should facilitate subsequent investigations on the virus and cellular factors participating in virus development.
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